Tommy Chong Lights World-Record 23-Pound Blunt ‘Up in Smoke’ in Bel Air, California

Stoner Icon Celebrates His 86th Birthday by Planting Himself in the History Books Yet Again With the Help of Legendary Rollers

In a legendary feat of craftsmanship and “stoner ingenuity,” Tommy Chong, celebrated comedian, actor, and icon, has shattered the world record for smoking the largest handcrafted blunt. The previous record stood at just over five pounds, but Chong, along with world-class rollers Dawn “Grasshoppa” Doan and June Da Goon, champions of both the World Rolling Championship and the National Joint League, achieved the unimaginable with a 23.36-pound blunt containing a colossal 21 pounds (9,555g) of marijuana. The monumental event coincides with Tommy Chong’s 86th birthday later this week, making it a double celebration for the cannabis community and fans worldwide. 

The event was a testament to the passion and dedication of the cannabis community. Dawn “Grasshoppa” Doan, the world’s first professional female roller, Rolling Champion, and judge, featured in Forbes, High Times, and Vice magazine, expressed her excitement. “It’s moments like this that make all the years of rolling worth it. June and I have been rolling professionally for over 10 years, and to be part of such a historic achievement with a legend like Tommy is beyond words.”

June Da Goon, a five-time rolling champion featured in High Times magazine and on Leafly, highlighted the uniqueness of this blunt. “Most blunts over a couple pounds have to be hooked up to a fan blower. At 20 pounds, this was a feat beyond measure to rip huge clouds using nothing but lung power. There may have been other big rolls, but they didn’t smoke.”

James Alexander, a key organizer of the event, emphasized the significance of its non-commercial nature. “This was a non-sponsored event, completely free of commercialization. It was important for us to do this for the love of the plant and the community. We wanted to celebrate cannabis culture in its purest form, and I believe we succeeded.”

Chong commented on the achievement and its recognition. “The Guinness Book of Records might not be ‘honoring’ cannabis-related records right now, but I know in my heart we set the record here today. It was an honor to take the first toke. Plus, who needs to be in a record book when you’ve got a blunt this big?”

The historic smoke out, captured on video, showcases the spirit of unity and creativity within the cannabis community. Fans and enthusiasts can witness the record-breaking moment and join the celebration by watching the video on YouTube.

As Tommy Chong turns 86 on May 24, his enduring influence and love for the plant continues to inspire. This record-breaking event not only honors his contributions to the culture but also highlights the vibrant and innovative spirit of the community as a whole.

For more information and to see more exclusive Cheech & Chong content, visit Bowlmates.com.

Source: Cheech and Chong’s Cannabis Company

Pioneering Synergy of Innovation and Purpose: The Futurist Showcase at the Pierce School Penthouse Featuring Global Cannabis Holdings and Avi8ted Ventures

The stage is set for a symphony of innovation and purpose as the Futurist Showcase takes center stage August 18, at 7:15 p.m.

This exclusive event, a convergence of luminaries, will spotlight two trailblazing enterprises — Global Cannabis Holdings (GCH) (https://globalcannabisholdings.lu) and Avi8ted Ventures (https://avi8tedthoughts.com). These visionary companies are poised to reshape industries and redefine societal progress, all against the backdrop of the exquisite Pierce School Penthouse, a residence synonymous with entrepreneurial spirit and forward-thinking excellence.

The visionary forces behind the Futurist Showcase are entrepreneurs Charlton Woodyard II, CEO of Avi8ted Ventures, and Brock Pierce, the President of the Bitcoin Foundation, whose remarkable journey spans technology, real estate, and social impact. Pierce’s commitment to pioneering change and igniting community empowerment finds a fitting home in the profound ambiance of the Pierce School Penthouse. “Brock Pierce is an inspiration to any builder with his ability to make change happen across the world in every industry he touches. We are incredibly grateful that he has opened his home to us for this amazing opportunity to present our mission to the world,” said David Luftglass, Chairman, Global Cannabis Holdings.

An assembly of Washington, D.C.’s foremost leaders, policy architects, artistic trailblazers, investors, educators, and catalysts for change will grace the gathering. Hosted at the largest penthouse in the city, The Pierce School Penthouse, this event creates an unparalleled platform for collaborative engagement, fostering the coalescence of ideas and collective growth. The Showcase’s compelling mission, empowering individuals to champion change in their communities, resonates profoundly in the context of this prestigious locale.

In an era where innovation and purpose dictate the trajectory of tomorrow, the Futurist Showcase stands as a beacon of transformative potential. From the heights of the Pierce School Penthouse, a space resonating with entrepreneurial verve, this event catalyzes more than dialogue; it ignites a movement.

About Avi8ted Ventures

Avi8ted Ventures is a dynamic and innovative force at the intersection of real estate, technology, and culture. More than a social network, Avi8ted Ventures operates as an experimental ecosystem where the physical and digital realms merge, fostering a sustainable impact ecosystem. By harnessing the collective power of real estate, technology, and culture, Avi8ted Ventures initiates a global movement of change, driving innovation, collaboration, and social progress. As a platform where ideas materialize, pioneers unite, and the future takes shape, Avi8ted Ventures empowers individuals, transitions humans to beings, and facilitates transformative journeys of lasting impact.

About Global Cannabis Holdings (GCH)

Global Cannabis Holdings (GCH) began in Uruguay as a pioneering force in the international cannabis sector. With a groundbreaking tokenized portfolio of cannabis companies, GCH is redefining the future of this rapidly growing industry. GCH has obtained ownership in 38 companies across 6 countries, all wrapped up into one entity, offering a diversified approach to investing in cannabis. The holdings include everything from a six square kilometer production project in Uruguay, to the top distributor in Brazil, and the largest extraction group in California. With a visionary, forward looking approach, GCH is poised to catalyze change on a global scale by embracing the remarkable possibilities of cannabis. GCH recently underwent its public launch in the Luxembourg market via the STOKR platform, the first registered Security Token Exchange in the European Union. For more info on the launch please check out www.stokr.io/global-cannabis-holdings

For media inquiries, interviews, and additional information, please contact:
Avi8ted Ventures
Charlton Woodyard II
(202) 888-5326
Info@av8t.co

VapeEZ Launches NEXCORE DUAL BOOST: Pioneering Brand with Ultra High Capacity Dual Mesh Technology

With the continuous iteration and advancement of electronic cigarette technology, the latest concept of disposable electronic cigarettes, dual mesh coil, has attracted attention. As the pioneer of high-capacity dual mesh coil technology, VapeEZ always keeps in mind the mission of “Vaporization technology changing lifestyle” and has launched groundbreaking NEXCORE Dual Boost, the first platform to adopt high-capacity dual mesh coil technology for double cloud and greater taste in the market. With outstanding technological innovation capabilities, VapeEZ collaborates with brand partners to take the lead in the field of electronic vaporization for maximized puffs and help customers achieve commercial success.

The idea of Nexcore Dual Boost was born three years ago, and after more than 800 days of research and over 20,000 analytical experiments, it has finally been introduced. It has already acquired 90% of the invention patents and utility model patents in this field, representing the cutting-edge technology in the electronic vaporization industry.

Unlike the common dual mesh configurations on the market, Nexcore Dual Boost breaks away from the traditional top-and-bottom structure and offers a unique mode that not only satisfies users’ ultimate taste experience but also caters to the pursuit of large capacity and high puff counts. It provides a perfect solution for balancing taste and capacity, making it more suitable for high-capacity and maximized puff atomizers, showcasing an exciting and cost-effective option with as twice as much cloud and taste experience.

NEXCORE DUAL BOOST, an intelligent dual mesh cutting-edge technology, strives for providing an all-round solution to double both the cloud and taste experience. It has a faster heating start-up speed, stable and uniform heating, and significantly improved heating efficiency. It extends the lifespan of the heating coil and greatly improves the utilization of juice, truly satisfying the desire for dense vapor inhalation. It restores delicate flavors that never fade, ensuring a longer and upgraded taste experience.

Equipped with NEXCORE DUAL BOOST dual mesh products, known for their originality and high cost-effectiveness, they continuously double full-bodied vapor, restoring a genuine and rich taste, ensuring consistent and delicate flavors. As a first-striking mature dual mesh technology, it quickly captures the market with a potential shipment volume of up to 20 million and a production efficiency improvement of 99%.

About VapeEZ
VapeEZ, as an experienced manufacturer of closed-system pod mods and disposable vapes, is the first to provide a high-capacity dual mesh technology solution. It has established the Qingdao Research Institute and a laboratory in the United States, conducting in-depth research in materials, chemistry, biology, electronics, and other fields. With innovation as its technological gene and user experience as its R&D orientation, VapeEZ continuously brings higher-quality vaporization experiences to users. All the goodness begins with the “core”.

For more information about brand and products, please visit official website at https://myvapeez.com/?nexcore-dual-boost/.

Business Contact: marketing@myvapeez.com

Media Contact
Fiona Wang, Shenzhen VapeEZ Technology LTD
Shenzhen, Guangdong, China
Email: marketing@myvapeez.com
Tel: +8617322371918
Website: https://myvapeez.com/?nexcore-dual-boost/

WEED Australia Ltd is Proud to Announce the Appointment of Ms. Amanda Brunskill-Scott and Mrs. Nicole Breen as Members of our Board of Directors

  • Ms. Brunskill-Scott will also take over the role of Managing Director and Corporate Secretary, while Mrs. Breen will take over the additional role and responsibilities of treasurer.

WEED Inc. (OTCQB:BUDZ), (WEED or the Company) a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases.

WEED Israel (Cannabis) Ltd
WEED Australia Ltd
WEED Hong Kong Ltd

Wholly owned subsidiary HEMP Biosciences Inc. is pleased to announce that it received its hemp cultivation license from the state of Arizona. The license allows for cultivation, process and manufacture of hemp for the production of low THC & CBD products.

In addition, Ms. Brunskill-Scott has been appointed as our in-house counsel for both WEED Australia Limited and the Cannabis Institute of Australia. While Mr. Patrick Brodnik, will continue to promote the Corporate Business Development for WEED Inc. USA and continue working on strategic partnerships and cannabis acquisitions for WEED Australia Limited.

We would like to take this opportunity to express our heartfelt gratitude to Mr. John J. Foley, who recently retired from our Australian management & Board of Directors. Glenn E. Martin CEO comments, “John has been a faithful servant to our company since the beginning, and we wish him a well-deserved retirement at the young age of 85 years old. We look forward to his continued advice and counsel in the future.”

Ms. Brunskill-Scott is an advocate for the indigenous peoples of Australia and grew up in the Northern Territory, as her family is both indigenous Australians and from Papa New Guinea. Her appointment to our Board of Directors reflects our commitment to diversity and inclusion, and we are excited to have her leadership and vision driving our company forward. Darwin and the Far Northern Territories such as Cape York which are top of our list for cannabis cultivation.

Ms. Brunskill-Scott announces, “I’m excited and privileged for the opportunity before me to lead the team WEED Australia has established over the past 7 years. Surviving Covid hardships has strengthened our resolve to find natural plant remedies to complex medical conditions. WEED Australia and the Cannabis Institute looks to lead the charge in cannabis research and product development making it affordable to all compared to the current market situation.”

Mrs. Breen states, “The cannabis industry in Australia is on the global forefront. WEED was incorporated in March 2017 as an ASIC regulated entity. Post Covid WEED looks to ready an IPO for the ASX once economic condition warrants. I am excited to work with Amanda and bring WEED Australia to its full potential in the cannabis and hemp space.

WEEDs key to success is our rare Landrace cannabis genetics grown and kept F-1 grade over 40-50 years, while scientific research and development will ensure year over year returns for our investors as we build a premier cannabis company in Australia.”

WEED Australia Ltd is dedicated to developing innovative products and services for the Australian people utilizing the amazing cannabaceae plant.

Our nonprofit arm, the Cannabis Institute of Australia, is focused on cannabis & hemp research including clinical trials for pharma and non-pharma product and services.

With the appointment of Ms. Brunskill-Scott and Mrs. Breen, we are confident that WEED Australia Limited as a majority owned subsidiary of WEED Inc (USA) will continue to grow and thrive as a global cannabis holding company. WEED Australia Ltd. formed in March 2017 was the first cannabis pubco, ASIC regulated, in Australia with an American parent.

WEED, Inc.’s Subsidiaries past comments:

WEED Israel (Cannabis) Ltd. “After over 3 years of putting human clinical trials and product development on hold due to COVID, WEED Israel is poised and anxious to build out our global brands in both pharmaceutical and non-pharmaceutical categories, starting with women’s health and veterans’ ailments (PTSD) to healthy green alternative medicines” stated Elliot Kwestel, Managing Director of WEED Israel (Cannabis) Ltd. based outside Jerusalem.

Kwestel further commented, “WEED Israel looks to enrich and expand our clinical trials with both THC and Cannabinoid studies to promote healthy living for generations to come.”

WEED Australia Ltd. and The Cannabis Institute of Australia (C.I.A.), our Australian non-profit arm, based in Queensland on the Gold Coast.

Corporate Director Patrick Brodnik stated, “With the new rules out governing cannabis & hemp in Australia and the announcement in February 2021 to allow over-the-counter CBD medicines in pharmacies, now after Covid, timing is perfect to begin our clinical trials in Israel and Australia to bring new curative products to market as we close out COVID mandates this year.

Managing Director Brunskill-Scott commented “Next year 2024, the future of USA & Australia decriminalizing cannabis and hemp globally will prove to be a giant leap forward for worldwide cannabis legalization.”

WEED Hong Kong Ltd. Director Nicole Breen agrees, “The pandemic has affected all of us on a worldwide basis. Healing our planet with natural therapies, treatments and eventual “cures” utilizing natures’ own Cannabaceae plant with its many properties, both with high tetrahydrocannabinol (THC) and cannabidiol (CBD) compounds, I believe will change the force of medicine forever in the years to come. We look forward to an exciting year end and a Prosperous 2022.

Caution Regarding Cannabis Operations in the United States:
Any Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. While legal in certain states, cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis.

That all Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation. That Investors should carefully read the risk factors and disclosures contained in our offering circular before making any decision to invest in our company.

Forward Looking Information:
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “potential”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and include statements with respect to any future revenue and profits.

Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct.

Actual results and developments may differ materially from those contemplated by these statements.

Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. The statements in this press release are made as of the date of this release.

That the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws for the relevant country.

Legal Notice:
That the information is provided for convenience only, it is not investment advice and may not be relied upon in considering an investment in WEED, Inc.

That No representation or warranty, express or implied, is made as to the accuracy or completeness of any information contained herein, and any investment decision should be based solely on the information contained in the offering circular and related materials, and the investors independent research.

We advise that No representations or warranty, express or implied, is made as to the future performance of any investment in WEED, Inc. or that investors will or are likely to achieve favorable results, will make any profit at all or will be able to avoid incurring a loss on their investment.

In addition, all prospective investors are encouraged to consult with their financial, tax, accounting, or other advisors to determine whether an investment in WEED, Inc. is suitable for them.

Media Contact:
Glenn E. Martin, CEO
1-520-818-8582
Glenn@WEEDincUSA.com

Malaysian Genomics to Collaborate on Cannabinoid R&D

  • Group joins MAHSA University and Kensana Health to develop phytopharmaceutical and biotechnology products for commercialisation

Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation.

Dato’ Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics

Kensana Health Canada is a biotechnology specialist focused on the R&D of cannabinoid treatments and management of wounds partnered with a German multinational phytopharmaceutical company. MAHSA University is a private Malaysian university focused on allied health sciences with a 48-acre campus in Bandar Saujana Putra, Selangor and a diverse population of students from 75 countries.

The strategic collaboration involves all three parties conducting joint R&D on species improvement, identification, formulation and pre-clinical testing of novel phytocompounds with potential therapeutic and commercial value, among other areas.

Dato’ Alvin Joseph Nesakumar, Executive Director of Malaysian Genomics said, “The Group welcomes this strategic collaboration with MAHSA and Kensana to expand R&D activities utilising plant-based formulations to produce results that can be commercialised in countries where the law allows the use of cannabinoid medications. In Malaysia, there are also moves to register cannabidiol products this year.”

“We have the market knowledge and expertise in the distribution of healthcare-related products while our track record of collaborations and partnerships will help support the Group’s focus on the biopharmaceuticals business for growth and sustainability. We also have necessary lab equipment to support the R&D efforts.”

Mr. Ken Clement, Chairman and CEO of Kensana Health Canada said, “We look forward to working with Malaysian Genomics and MAHSA by providing our technology and knowledge in advancing the R&D efforts. We have the proprietary knowledge as well as the proven techniques in standardised cannabinoid crops and recipes and have a unique approach to wound management where we are a worldwide leader.”

Dato’ Dr. Shahril bin Tan Sri Prof. Datuk Haniffa, Group Managing Director of the MAHSA group of companies and MAHSA University said, “This collaboration brings together parties with expertise and knowledge in their fields that we look forward to working and sharing with in areas that the university is interested to see expanded on. Besides identifying novel bioactive compounds with potential therapeutic uses, the collaboration includes offering education and training programmes to stakeholders, inclusive of health professionals, educational institutions and hospitals that is also an important component of advancing the health sciences.”

Malaysian Genomics Resource Centre Bhd: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

WestCann Commercializes Reconstituted Cannabis

Patented tobacco processing technology expected to be disruptive to the recreational cannabis pre-roll market

WestCann Holdings Ltd. (WCH or the Company) is pleased to announce that it has signed an agreement with IOTO USA, LLC (IOTO) for the exclusive global licensing of all uses with cannabis and hemp of IOTO’s patented technologies for the reconstitution of plant matter.

Originally developed for the primary processing of tobacco, IOTO’s technologies allow for complete homogenization of cannabis as well as for full process control over the active ingredients and smoking characteristics. As a result, precision tobacco cigarette making and packaging equipment can be utilized for pre-roll manufacturing, creating a highly consistent and reproducible consumer product with significant quality and cost advantages.

The Company’s wholly owned subsidiary WestCann Processors Inc. is planning to start the manufacturing of reconstituted cannabis pre-rolls for the Canadian recreational market at its Yorkton, SK facility by December 2022 and expects its products to be available to consumers through licensed retail stores in early 2023.

CEO Andreas Gedeon: “I’m convinced that our products will be disruptive to the existing pre-roll market, which is one of the single biggest growing segments in the cannabis industry. I believe that consumers will quickly appreciate our convenient format and the fact that they can always get the same experience with the next pack they purchase, all at a discount to what they are used to paying right now.”

The exclusive license to IOTO’s technologies complements WestCann’s portfolio of custom engineered automatization solutions, including its patented child resistant hinge lid pack that is certified for use in Canada, the U.S., Switzerland and the EU.

Over the course of the next year, the Company plans on partnering with licensed operations in several U.S. states for additional installations of its fully automated pre-roll making and packing lines, as well as on preparing to be a first mover in the upcoming recreational cannabis markets in Germany and Thailand.

For further information please visit www.westcann.com or contact Andreas Gedeon, CEO at andreas@westcann.com.

About WestCann
WestCann Holdings Ltd., based in Perth, WA and its wholly owned subsidiaries WestCann Processors Inc, 102021671 Saskatchewan Inc. in Canada and Laika Brands, LLC in Nevada are focusing on the transfer of tobacco processing technologies to the recreational cannabis markets. For more information on WestCann please visit www.westcann.com.

About IOTO
IOTO USA, LLC, a subsidiary of IOTO International in Brazil, is a global leader in the provision of flavorings and reconstitution technologies for tobacco. For more information on IOTO please visit www.iotointernational.com.

PRESS RELEASE CONTACT
Andreas Gedeon
+1 (250) 713-6302
andreas@westcann.com

Get Half Baycd: The Future of Web3 Cannabis

One of the greatest hurdles in the Web3 space is creating opportunities without creating violations; we set out to bring ownership of a cannabis company to our holders and we were determined to do it in a way that didn’t bring forth securities violations and ensure longevity and sustainability are our primary focus.

We’ve created Half BAYCD as an opportunity for our pass holders to either license their own BAYC/MAYC/BAKC/Koda or partner with a holder and do a revenue share on the licensing of the IP.

By leveraging the royalty structure we’re able to offer a 50% net profit share agreement to be equally distributed amongst licensees for the brand, essentially 6,969 people become “owners” of a multi-national cannabis brand built around Web3 culture.

The variety of passes

We’ve gamified our passes to offer tiered benefits and fun to be a holder, we have 7 pass tiers, all of which allow licensing to the cannabis brand.

BAYCD Pass: The BAYCD Pass allows you to license an asset, or partner with an asset holder to co-license the asset to the Half BAYCD brand. The BAYCD Pass shares a 30% participation pool.

Stoner Pass: The Stoner Pass carries the same benefits as the BAYCD Pass but also grants 20% off of Half BAYCD products at retail partners and our online store. The Stoner Pass shares the same 30% participation pool as above.

420 Pass: The 420 Pass brings with it the same licensing opportunities and 20% cannabis discounts but also adds a quarterly cannabis care package that will be claimable in participating licensed regions. The 420 Pass shares the same 30% participation pool as above.

Merch Pass: The Merch Pass brings with it the same licensing opportunities and 20% cannabis discounts but also adds a quarterly merch care package that will be redeemable on our e-commerce store with each new drop. The Merch Pass shares the same 30% participation pool as above.

Pack Pass: The Pack Pass brings forth a new licensing opportunity as well as its own unique 10% participation pool that is divided amongst the lucky 420 that hold one. Our Pack Pass guarantees that your asset will be used on packaging/branding.

Club Pass: The Club Pass has a unique advantage in which you have direct involvement in the brand curation and development — this pass doesn’t require licensing to receive a participation share. The Club Passes have their own 10% participation pool shared amongst the 100 lucky holders.

Pheno Pass: The Pheno Pass is for the lucky chosen few, there are only 10 of them to be minted — the Pheno Pass doesn’t have a shared participation pool but rather takes you on a journey. You will be able to pheno hunt and create your own genetics which you then license to us for use.

Wen product

We’ve been working on our packaging and branding for the last 6 months, packaging design work should be finalized at the end of August and production will take roughly 6 weeks.

Our initial launch cities will be LA, Denver, Vegas, and NYC – we are an ancillary goods company, we’re non-plant touching and that enables us to insulate our holders from the cannabis industry regulations.

We’re excited for the forthcoming announcement that outlines our production partners in each location and the value-add that they bring to the brand.

We also own equity in the patents for sublingual strips with cannabinoids, it’s one of the flagship products that we are excited to bring to market. We handed out thousands of them during NFT NYC and received amazing feedback and debuted the first time that Kodas have been licensed to physical goods.

Wen mint

Our mint is currently live, we have 6969 passes that are minting at .069E — if you’re interested in joining the Half BAYCD family, you can mint at halfbaycd.com.

If you have questions on the project or would like to learn more, we welcome you to join us on Twitter at @halfbaycd and also in discord at discord.gg/halfbaycd.

Source: Plato Data Intelligence: Platodata.ai

VOOPOO and ZOVOO Shine as Joint Exhibitors at the 2022 Malaysia Vape Show

The two-day Malaysian Vape Show (MIVAS) concluded successfully on March 27. The show brought together more than 100 exhibiting brands worldwide and attracted over 5000 professional visitors.

As two of the most influential VAPE brands in Southeast Asia, VOOPOO and ZOVOO attracted the most visitors to the exhibition hall with their unique booth design, simple brand image, and amazing product experience.

As the pioneer of technological change in the industry, VOOPOO and ZOVOO jointly exhibited at the 2022 MIVAS, discussing the future development trend of the industry and the upgrade and innovation of product experience with many partners, fans and users, and business competitors.

Joint exhibition attracts widespread attention
As two of the most influential VAPE brands in Southeast Asia, VOOPOO and ZOVOO attracted the most visitors to the exhibition hall with their unique booth design, simple brand image, and amazing product experience. Many local fans lined up in long queues to participate in the on-site interaction and product experience.

At the same time, many local distributors and retailers appreciated VOOPOO and ZOVOO’s extensive product lines, especially VOOPOO’s newly developed ARGUS GT 2 and ZOVOO’s DRAGBAR5000 and DRAGBAR5000C sugar-free concept products. They kept asking for and showing strong interest in cooperation.

The feedback from the dealers on site said, “The VOOPOO ARGUS GT 2 is extremely powerful with its 200W power and stunning triple defense design. ZOVOO’s product design is bold and innovative, taking into account not only the user’s feelings but also the aesthetic design, and the price is quite competitive.”

The pinnacle of brand-new research and development
The ARGUS GT 2, VOOPOO’s first MOD product of 2022, inherits the classic style of the ARGUS GT and brings the best of technology and design to the show floor, which numerous vapers have well received since its launch at the show.

ARGUS GT 2 has a sense of technology and design from appearance to usage. It is designed with leather and metal, and every texture is solid and powerful. From the distinctive metal body to the finely crafted leather texture, every detail is a classic. The new ARGUS GT 2 combines luxury craftsmanship and technology for a comfortable grip and a solid visual impact.

It has up to 200W high power constant voltage stable output, IP68 tri-proof design, innovative volcano air channel mouth leak-proof design, GENE.TT 2.0 chip, 6.5ml large capacity, 3A TYPE-C fast charging, etc. The newly developed MAAT TANK NEW atomizer has defined a new height of experience. The unveiling of the new ARGUS GT 2 has also amazed the audience and has been well received.

ZOVOO DRAGBAR innovative sugar-free products
As a disruptor in the overseas Pod market, ZOVOO launched the industry’s first sugar-free disposable e-cigarettes, DRAGBAR 5000 and DRAGBAR 5000C, which innovatively use ethyl malt alcohol to provide sweetness of the vape oil. As an alternative to cane sugar certified by authorities in many countries, ethyl malt alcohol ensures sweetness without additional sugar intake, effectively avoiding the harmful effects of sugar addiction on the body. It is a great choice for those who are sugar-free or less sugar-intensive.

As ZOVOO’s flagship product, the DRAGBAR range has gained attention and interest from users worldwide since its inception. The use of ethyl malt alcohol in ZOVOO is not only a demonstration of ZOVOO’s deep understanding of user needs but also a new definition of disposable e-cigarettes. It will become a major milestone in the industry and open up a new era of sugar-free e-cigarettes.

It is understood that the ZOVOO team discovered the spitting and bursting problems of disposable e-cigarettes after surveying 3,000 global users. After a year of research and tens of thousands of trial tests, the ZOVOO team found a solution. ZOVOO’s mesh coil dramatically improves the atomization performance of disposable e-cigarettes and solves the spitting and bursting problem of disposable e-cigarettes. Meanwhile, DRAGBAR 5000 employs silicone preservation technology to lock in freshness extremely well and guarantee its fullness.

The ZOVOO team’s optimization of product details and taste guarantee has made ZOVOO DRAGBAR popular among a wide range of users in North America, Europe, Southeast Asia, and other regions.

In future, VOOPOO and ZOVOO will always adhere to the original intention, sticking to the “user first” product concept. They will pursue innovation and breakthroughs in technology and continue to launch a richer and more diversified product selection, committed to providing a safer and more enjoyable product experience for consumers worldwide. They will work with partners to continue to layout offline channels at home and abroad and provide partners with a full range of support solutions in the product, logistics, branding, and marketing to build an innovative and diversified ecological cooperation.

WARNING: This product may be used with e-liquid products containing nicotine. Nicotine is an addictive chemical.

Media contact:
Wind Chen, VOOPOO
E: wind.chen@voopoo.com
U: https://www.voopoo.com/
T: +86-18718743237

NextPlay Technologies Longroot Selected by Ample Health to Lead Security Token Offering

NextPlay Technologies, Inc. (NASDAQ: NXTP), a digital business ecosystem for digital advertisers, consumers, video gamers and travelers, reported that its licensed Longroot digital token offering platform will serve as the financial advisor and underwriter for Ample Health’s (‘Ample’) proposed security token offering (STO).

Ample Health is an emerging cannabis company operating from seed to sale in Southeast Asia. The company is looking to use the proceeds from its STO to fund its development and global expansion.

Longroot will be responsible for structuring the offering and raising the initial capital to fund the STO. This will involve developing the registration statements for all relevant jurisdictions, including preliminary and final prospectuses. It intends to lead Ample through the entire regulatory approval process, and then assist in the pricing and launching the STO through the Longroot portal.

“This Ample Health STO represents a tremendous opportunity for us to represent a major client in the fast-growing global cannabis space,” commented Todd Bonner, director of Longroot (Thailand) Limited and chairman of NextPlay Technologies. “Once complete, we believe it will represent the first of many successful STOs for Longroot that we are currently advancing in our pipeline.”

Ample Health looks to take advantage of the global cannabis market which is projected to grow at a 32% compounded annual growth rate from $28.3 billion in 2021 to $197.74 billion by 2028, according to Fortune Business Insights.

Akira Wongwan, CEO and co-founder of Ample Health, commented: “We selected Longroot to lead our STO due to its experienced management and well-established presence in the digital offering marketplace, as well as its Thai federal government licensing and oversight. Together, we believe this will ensure a highly-successful STO and the launch of our global cannabis platform.”

The proposed offering targets to raise between USD $100-250 million. Longroot will receive a management and placement fee on the proceeds raised due immediately upon closing of the offering, which is expected to occur by the summer of 2022.

Disclaimer
The information included in the press release is for informational purposes only. It is not intended to be, nor should it be construed as, an offer or solicitation for the purchase or sale of any financial instrument, security or digital currency, or as an official confirmation of any transaction. All market information, data and other information included herein are not guaranteed as to completeness or accuracy and are subject to change without notice.

This press release is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Ample Health and will contain detailed information about the company and management, as well as financial statements.

About Ample Health

Ample Health is an emerging cannabis company operating from seed to sale in Southeast Asia. It is focused on bringing synergy between growers, extractors, retailers and regulators, to help them compete in the domestic and international cannabis market and creating a fair and sustainable industry for all.

About Longroot

Authorized and regulated under global-leading Thai federal digital asset business law and licensed by the Securities & Exchange Commission of Thailand, Longroot (Thailand) Limited provides fully regulated and licensed digital asset financing and investment services for digital assets. Longroot is focused on creating regulated cryptocurrencies used in wholesale travel, real estate and hotels, gaming assets, insurance and digital advertising. As a Thailand-based corporation, Longroot is indirectly controlled by NextPlay Technologies. For more information, go to longroot.co.th.

About NextPlay Technologies
NextPlay Technologies, Inc. (Nasdaq: NXTP) is a technology solutions company offering games, in-game advertising, crypto-banking, connected TV and travel booking services to consumers and corporations within a growing worldwide digital ecosystem. NextPlay’s engaging products and services utilize innovative AdTech, Artificial Intelligence and Fintech solutions to leverage the strengths and channels of its existing and acquired technologies. For more information about NextPlay Technologies, visit www.nextplaytechnologies.com and follow us on Twitter @NextPlayTech and LinkedIn.

Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of, and within the safe harbor provided by the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations, opinions, belief or forecasts of future events and performance. A statement identified by the use of forward-looking words including “will,” “may,” “expects,” “intends,” “projects,” “anticipates,” “plans,” “believes,” “estimate,” “should,” and certain of the other foregoing statements may be deemed forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, these statements involve risks and uncertainties that may cause actual future activities and results to be materially different from those suggested or described in this news release. Factors that may cause such a difference include risks and uncertainties including, and not limited to, our need for additional capital which may not be available on commercially acceptable terms, if at all, which raises questions about our ability to continue as a going concern; the fact that the COVID-19 pandemic has had, and is expected to continue to have, a significant material adverse impact on the travel industry and our business, operating results and liquidity; current regulation governing digital currency activity is often unclear and is evolving; the future development and growth of digital currencies are subject to a variety of factors that are difficult to predict and evaluate, many of which are out of our control; the value of digital currency is volatile; amounts owed to us by third parties which may not be paid timely, if at all; certain amounts we owe under outstanding indebtedness which are secured by substantially all of our assets and penalties we may incur in connection therewith; the fact that we have significant indebtedness, which could adversely affect our business and financial condition; our revenues and results of operations being subject to the ability of our distributors and partners to integrate our alternative lodging rental (ALR) properties with their websites, and the timing of such integrations; uncertainty and illiquidity in credit and capital markets which may impair our ability to obtain credit and financing on acceptable terms and may adversely affect the financial strength of our business partners; the officers and directors of the Company have the ability to exercise significant influence over the Company; stockholders may be diluted significantly through our efforts to obtain financing, satisfy obligations and complete acquisitions through the issuance of additional shares of our common or preferred stock; if we are unable to adapt to changes in technology, our business could be harmed; our travel business depends substantially on property owners and managers renewing their listings; if we do not adequately protect our intellectual property, our ability to compete could be impaired; our long-term success depends, in part, on our ability to expand our property owner, manager and traveler bases outside of the United States and, as a result, our business is susceptible to risks associated with international operations; unfavorable changes in, or interpretations of, government regulations or taxation of the evolving ALR, Internet and e-commerce industries which could harm our operating results; risks associated with the operations of, the business of, and the regulation of, Longroot and NextBank International (formerly IFEB); the market in which we participate being highly competitive, and because of that we may be unable to compete successfully with our current or future competitors; our potential inability to adapt to changes in technology, which could harm our business; the volatility of our stock price; the fact that we may be subject to liability for the activities of our property owners and managers, which could harm our reputation and increase our operating costs; and that we have incurred significant losses to date and require additional capital which may not be available on commercially acceptable terms, if at all. More information about the risks and uncertainties faced by NextPlay are detailed from time to time in NextPlay’s periodic reports filed with the SEC, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, under the headings “Risk Factors”. These reports are available at www.sec.gov. Other unknown or unpredictable factors also could have material adverse effects on the Company’s future results and/or could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and actual results or developments may differ materially from those projected. The forward-looking statements in this press release are made only as of the date hereof. The Company takes no obligation to update or correct its own forward-looking statements, except as required by law, or those prepared by third parties that are not paid for by the Company. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

SOURCE: NextPlay Technologies, Inc.

Company Contacts:
NextPlay Technologies, Inc.
Richard Marshall
Director of Corporate Development
Tel: (954) 888-9779
Email: richard.marshall@nextplaytechnologies.com

Ample Health
Akira Wongwan
Founder
Tel: 0869778788
Email: a.wongwan@gmail.com

Heartland and Ravago Develop Products to Reduce the Carbon Footprint of Plastic

Heartland and Ravago Americas have executed a joint development agreement to create the next generation of plastic resins. This collaboration aims to drive material innovation for companies that buy large volumes of plastic. Heartland’s hemp additives will help these manufacturers reduce the cost, weight, and carbon footprint of the raw materials they rely on every day.

Ravago is one of the world’s largest plastic recyclers, compounders, and distributors. Ravago and its subsidiaries service over 50,000 customers globally across 325 facilities in 55 countries. Annually, they supply over 6.6 million MT of polymer and rubber. Heartland is building America’s first reliable industrial hemp supply chain to provide additives for manufacturers that use plastics.
By leveraging carbon-negative and renewable plastic additives like industrial hemp, Ravago can offer composite products that are stronger, lighter, cheaper, and more sustainable. Not only will these plastics have enhanced thermal and acoustic properties, but Heartland’s hemp additives help prolong the life of Ravago’s materials that use recycled content.

Heartland’s engineered hemp additives reduce the carbon footprint of virgin plastics by as much as 44%. Heartland is also focused on verifying the impact of hemp-filled recycled plastics versus traditional virgin plastics that are typically compounded with mineral fillers like talc and calcium carbonate.

Heartland has worked alongside Ravago to engineer their hemp materials as renewable additives for plastics. Ravago’s R&D team has guided Heartland in engineering products that do not require additional retooling costs for plastic compounders and molders.

After the 2022 farming cycle, Heartland estimates that they will be able to process over 100,000,000 pounds of hemp additives that will be available for plastic compounding. Ravago and Heartland will continue to research and develop products to serve automotive, packaging, building materials, and other markets.

About Ravago:

The Ravago group represents over 6.6 million metric tons of annual polymer sales serving more than 50,000 active customers through 325+ locations across more than 55+ countries worldwide. Ravago’s production competence consists of 45+ manufacturing facilities (recycling and compounding plants; production plants for the building sector; and plants and laboratories for its Chemicals business). This all would not have been possible without the help of its 8,000 employees. For more information, visit https://www.ravago.com.

About Heartland:

Heartland is a biotech company that engineers hemp fibers as additives for plastics. Their team is building America’s first reliable industrial hemp supply chain to provide additives for manufacturers that use plastic resins. As an industrial hemp material processor, they work with farmers and manufacturers to ensure the product consistency of bio-based additives that can be used across raw material supply chains. Heartland’s products help companies manufacture with stronger, lighter, cheaper, and more sustainable materials. For more information, visit https://www.heartland.io.

Media Contacts:
John Ely, CMO
Heartland Industries
john.ely@heartland.io
or
Ashton Maxfield
Master Plan Communications
ashton@masterplancommunications.com
949.289.6493

Source: Plato Data Intelligence